Advarra

Healthcare

Central Institutional Review Board (“IRB”) focused on providing legally mandated oversight functions for research conducted on human subjects as part of the clinical trial process.  Advarra was formed in November 2017 through the merger of Chesapeake IRB and Schulman IRB.  Northlane Capital Partners originally invested in Schulman IRB in December 2014.

Related News

Related Team Members

Eugene Krichevsky

Partner

Justin DuFour

Partner

Scott Kauffman

Partner

JJ Carbonell

Partner